Our Company
Presentation
Management Team
Board of directors
Scientific Advisory Board
Contact
Products
Tedopi®
OSE-279
Lusvertikimab (OSE-127)
Pegrizeprument (FR104)
BI 770371
ABBV-230
CLEC-1
Research & Development
Scientific publications
Investors
Press Releases
Letter to Shareholders
Newsletters
Q & A
Financial documents
General Shareholders’ meetings
Regulated information
Partnerships
Pharma partnerships
Clinical partnerships
Academic and public Partnerships
News
Our videos
Agenda
Press Releases
Contact
en
fr
Projects Archives
September 2026
Webcast : Lusvertikimab & the IL-7R Pathway: An Expert Deep Dive into IBD
June 2026
Webcast : TEDOPI® (KOL event)
March 2026
14th Degroof Petercam Healthcare Conference
March 2026
Mardi de la Bourse – Lyon Pôle Bourse (retail event)
February 2026
ALLINVEST SECURITIES BIOMED FORUM 2026
May 2025
2025 ASCO Annual Meeting
February 2025
Lusvertikimab & the Future of IBD: KOL Insights Post-ECCO
February 2025
Smallcap Event, Paris
December 2024
20th Congress of European Crohn’s and Colitis Organization (ECCO)
December 2024
2025 JPM HEALTHCARE CONFERENCE
1
2
3
4
5
Suivant